Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideki Iijima

Showing results (141-150 of 186) with videos related to

Pageof 19
Sort By:
The American Journal of Gastroenterology|January 8, 2008
IgG oligosaccharide alterations are a novel diagnostic marker for disease activity and the clinical course of inflammatory bowel diseaseShinichiro Shinzaki, Hideki Iijima, Takatoshi Nakagawa, et al.
Oncology Letters|August 10, 2017
Clinical use of molecular targeted agents for primary small bowel adenocarcinoma: A multicenter retrospective cohort study by the Osaka Gut ForumMotohiro Hirao, Masato Komori, Tsutomu Nishida, et al.
Cancer Science|April 17, 2025
p53 Deficiency in Colon Cancer Cells Promotes Tumor Progression Through the Modulation of Meflin in FibroblastsEiji Kimura, Yoshito Hayashi, Kentaro Nakagawa, et al.
Journal of Gastroenterology|February 23, 2010
Roles of double-balloon endoscopy in the diagnosis and treatment of Crohn's disease: a multicenter experienceJumpei Kondo, Hideki Iijima, Takashi Abe, et al.
Endoscopy International Open|November 3, 2020
Effect of anticoagulants on the risk of delayed bleeding after colorectal endoscopic submucosal dissectionHideharu Ogiyama, Takuya Inoue, Akira Maekawa, et al.
Inflammatory Bowel Diseases|January 14, 2012
Deficiency of N-acetylgalactosamine in O-linked oligosaccharides of IgA is a novel biologic marker for Crohn's diseaseTakahiro Inoue, Hideki Iijima, Michiko Tajiri, et al.
Inflammatory Bowel Diseases|January 5, 2013
Lectin-based immunoassay for aberrant IgG glycosylation as the biomarker for Crohn's diseaseShinichiro Shinzaki, Eri Kuroki, Hideki Iijima, et al.
Ebiomedicine|September 16, 2019
Mucin O-glycans facilitate symbiosynthesis to maintain gut immune homeostasisTakahiro Yamada, Shingo Hino, Hideki Iijima, et al.
Inflammatory Intestinal Diseases|January 15, 2026
Safety and Effectiveness of Oral Budesonide after Endoscopic Balloon Dilation in Patients with Crohn's Disease: A Multicenter Prospective Intervention StudyYuriko Otake-Kasamoto, Takeo Yoshihara, Shinichiro Shinzaki, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|February 6, 2013
[Advanced gastric cancer deriving from submucosal heterotopic gastric glands based on pathological diagnosis]Dai Nakamatsu, Tsutomu Nishida, Takuya Inoue, et al.
Pageof 19

Showing results (141-150 of 186) with videos related to

Sort By:
Pageof 19
The American Journal of Gastroenterology|January 8, 2008
IgG oligosaccharide alterations are a novel diagnostic marker for disease activity and the clinical course of inflammatory bowel diseaseShinichiro Shinzaki, Hideki Iijima, Takatoshi Nakagawa, et al.
Oncology Letters|August 10, 2017
Clinical use of molecular targeted agents for primary small bowel adenocarcinoma: A multicenter retrospective cohort study by the Osaka Gut ForumMotohiro Hirao, Masato Komori, Tsutomu Nishida, et al.
Cancer Science|April 17, 2025
p53 Deficiency in Colon Cancer Cells Promotes Tumor Progression Through the Modulation of Meflin in FibroblastsEiji Kimura, Yoshito Hayashi, Kentaro Nakagawa, et al.
Journal of Gastroenterology|February 23, 2010
Roles of double-balloon endoscopy in the diagnosis and treatment of Crohn's disease: a multicenter experienceJumpei Kondo, Hideki Iijima, Takashi Abe, et al.
Endoscopy International Open|November 3, 2020
Effect of anticoagulants on the risk of delayed bleeding after colorectal endoscopic submucosal dissectionHideharu Ogiyama, Takuya Inoue, Akira Maekawa, et al.
Inflammatory Bowel Diseases|January 14, 2012
Deficiency of N-acetylgalactosamine in O-linked oligosaccharides of IgA is a novel biologic marker for Crohn's diseaseTakahiro Inoue, Hideki Iijima, Michiko Tajiri, et al.
Inflammatory Bowel Diseases|January 5, 2013
Lectin-based immunoassay for aberrant IgG glycosylation as the biomarker for Crohn's diseaseShinichiro Shinzaki, Eri Kuroki, Hideki Iijima, et al.
Ebiomedicine|September 16, 2019
Mucin O-glycans facilitate symbiosynthesis to maintain gut immune homeostasisTakahiro Yamada, Shingo Hino, Hideki Iijima, et al.
Inflammatory Intestinal Diseases|January 15, 2026
Safety and Effectiveness of Oral Budesonide after Endoscopic Balloon Dilation in Patients with Crohn's Disease: A Multicenter Prospective Intervention StudyYuriko Otake-Kasamoto, Takeo Yoshihara, Shinichiro Shinzaki, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|February 6, 2013
[Advanced gastric cancer deriving from submucosal heterotopic gastric glands based on pathological diagnosis]Dai Nakamatsu, Tsutomu Nishida, Takuya Inoue, et al.
Pageof 19